John Marsden - Ansell Chief Officer
ANN Stock | 32.44 0.29 0.90% |
Executive
John Marsden is Chief Officer of Ansell
Address | 678 Victoria Street, Richmond, VIC, Australia, 3121 |
Phone | 61 3 9270 7270 |
Web | https://www.ansell.com |
Ansell Management Efficiency
The company has return on total asset (ROA) of 0.0423 % which means that it generated a profit of $0.0423 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.044 %, meaning that it generated $0.044 on every $100 dollars invested by stockholders. Ansell's management efficiency ratios could be used to measure how well Ansell manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 532.4 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1.6 B in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
JP Howe | Oneview Healthcare PLC | N/A | |
Declan Bright | Oneview Healthcare PLC | N/A | |
Colin Hackwood | Oneview Healthcare PLC | N/A | |
Andrew CPA | Clime Investment Management | N/A | |
Xun Wang | Clime Investment Management | N/A | |
Forough Khandan | EMvision Medical Devices | N/A | |
James Trude | Clime Investment Management | N/A | |
John Kelly | Oneview Healthcare PLC | N/A | |
Gordon Martin | Viva Leisure | N/A | |
Konstanty Bialkowski | EMvision Medical Devices | N/A | |
Simon Dutton | Clime Investment Management | N/A | |
Niall ONeill | Oneview Healthcare PLC | N/A | |
Morgan Bryant | Viva Leisure | N/A | |
Matt Rencken | Clime Investment Management | N/A | |
Lyndal York | Fisher Paykel Healthcare | N/A | |
Darragh Lyons | Oneview Healthcare PLC | 43 | |
Karen Knott | Fisher Paykel Healthcare | N/A | |
Hayden Brown | Fisher Paykel Healthcare | N/A | |
Andrew Somervell | Fisher Paykel Healthcare | N/A | |
Toni Pettit | Oneview Healthcare PLC | N/A | |
Paul BCom | Fisher Paykel Healthcare | N/A |
Management Performance
Return On Equity | 0.044 | ||||
Return On Asset | 0.0423 |
Ansell Leadership Team
Elected by the shareholders, the Ansell's board of directors comprises two types of representatives: Ansell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ansell. The board's role is to monitor Ansell's management team and ensure that shareholders' interests are well served. Ansell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ansell's outside directors are responsible for providing unbiased perspectives on the board's policies.
Darryl Nazareth, Pres GBU | ||
John Marsden, Chief Officer | ||
MS MA, Chief Officer | ||
Michael Evans, Director Relation | ||
BA ACMA, CEO MD | ||
Charlotte Doll, Chief Officer | ||
Sean Sweeney, Chief Americas | ||
Zubair Javeed, Chief Officer | ||
Philippe Rommel, General Counsel | ||
Deanna Johnston, Chief Officer | ||
Augusto Accorsi, Chief APAC | ||
BS MBA, APAC EMEA | ||
Rob Hughes, Senior Unit | ||
Michael Gilleece, Senior Counsel | ||
Amanda Manzoni, Chief Officer |
Ansell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ansell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.044 | ||||
Return On Asset | 0.0423 | ||||
Profit Margin | 0.05 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 4.65 B | ||||
Shares Outstanding | 145.94 M | ||||
Shares Owned By Insiders | 1.32 % | ||||
Shares Owned By Institutions | 55.88 % | ||||
Price To Book | 1.63 X | ||||
Price To Sales | 2.92 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ansell Stock Analysis
When running Ansell's price analysis, check to measure Ansell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ansell is operating at the current time. Most of Ansell's value examination focuses on studying past and present price action to predict the probability of Ansell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ansell's price. Additionally, you may evaluate how the addition of Ansell to your portfolios can decrease your overall portfolio volatility.